Having medical documents in place before a health crisis can help make tough decisions easier and less stressful for families.

Soleno Therapeutics, Inc. (Soleno) (NASDAQ: SLNO), a biopharmaceutical company developing novel therapeutics for the treatment of rare diseases ...

European and FDA approval of Sephience (sepiapterin) with broad labeling for PKU - - Global launch underway in Europe and U.S. - - Total Q2 Revenue of $179M - ...

Detailed price information for Intellia Thera CS (NTLA-Q) from The Globe and Mail including charting and trades.

The U.S. Food and Drug Administration has approved the SetPoint System, a neuroimmune modulation device for the treatment of ...

Detailed price information for Crinetics Pharmaceuticals Inc (CRNX-Q) from The Globe and Mail including charting and trades.